Intraday MarketsStock report · MMED · MiniMed Group, Inc. · Nov 1, 2026
Intraday Markets
Home › Stocks › MMED

MMED Stock: Price, Earnings History and SEC Filings

MiniMed Group, Inc. (MMED) last traded at $18.28, down 5.04% on the latest session and down 6.1% over the past month. In its most recent reported quarter (Jul 2026) earnings per share were $0.00 against an analyst estimate of $0.09, a miss of 100.0%.

$18.28 -5.04%
1 month-6.11%
52-week high$24.43
52-week low$10.65
Volume8.13M
ExchangeNasdaqGS

Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.

MMED earnings history

QuarterReportedEPSEstimateSurprise
Jul 2026Sep 1, 2026$0.00$0.09-100.00%
Apr 2026Jun 3, 2026$-0.68$-0.21-223.81%

MMED beat the analyst EPS estimate in 0 of its last 2 reported quarters. Source: Nasdaq.

MMED financial history

Revenue
$2.5B2024$2.7B2025$3.1B2026
Net income
-$112M2024-$213M2025-$333M2026
Free cash flow
-$107M2024-$53M2025-$420M2026
Fiscal yearRevenueNet incomeFree cash flowNet marginDiluted EPS
2026$3.1B-$333M-$420M-10.7%$-1.30
2025$2.7B-$213M-$53M-7.8%$-0.84
2024$2.5B-$112M-$107M-4.5%$-0.44

Source: annual figures from 10-K filings on SEC EDGAR. The year shown is the calendar year the fiscal year ended. Free cash flow is operating cash flow minus capital spending.

Latest SEC filings for MMED

Insider filing activity

MMED insiders filed 17 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.

Source: SEC EDGAR.

MMED news

About MiniMed Group, Inc.

MiniMed Group, Inc. (MMED) is a US-listed public company on Nasdaq. The SEC classifies its business as Surgical & Medical Instruments & Apparatus. It is incorporated in DE. Its fiscal year ends in December.

Open the live terminal

Related stocks

NVDAAAPLMSFTGOOGLAMZNMETATSLAAVGOAll stocks
intradaymarkets.com · Information only, not investment advice · Data from public sources and may be delayed